Live feed
Filing
SC 13G/A
SC 13G/A0001535610-19-000013·Quoin Pharmaceuticals, Ltd.
Schedule 13G ownership disclosure
CELLECT BIOTECHNOLOGY LTD
Security class unavailable · CUSIP: 15116C102
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,000,000
- Percent of class
- 1.5300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-19-000013
- Form type
- SC 13G/A
- Filer
- Quoin Pharmaceuticals, Ltd.
- CIK
- CIK 1671502
- Filed
- Jan 03, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership